Estimation of vaccine efficacy against acquisition of pneumococcal carriage

Vaccine

Volumn 27, Issue 29, 2009, Pages 3831-3837

  Rinta Kokko, Hanna ^a   Dagan, Ron ^b   Givon Lavi, Noga ^b   Auranen, Kari ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Nasopharyngeal colonization; Streptococcus pneumoniae; Vaccine efficacy

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; CALCULATION; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NASOPHARYNX; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

CARRIER STATE; CROSS-SECTIONAL STUDIES; HUMANS; NASOPHARYNX; PNEUMOCOCCAL VACCINES; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 67349180204     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.009     Document Type: Article

References (37)

1. Obaro S.K., Adegbola R.A., Banya W.A.S., and Greenwood B.M. Carriage of pneumococci after pneumococcal vaccination. Lancet 348 (1996) 271-272
2. Dagan R., Muallem M., Melamed R., Leroy O., and Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphteria toxoid. Pediatr Infect Dis 16 11 (1997) 1060-1064
3. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., and Klugman K.P. Immunogenicity and impact of nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 180 (1999) 1171-1176
4. Dagan R., Givon-Lavi N., Zamir O., Sikuler-Cohen M., Guy L., Janco J., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185 (2002) 927-936
5. O'Brien K.L., Millar E.V., Zell E.R., Bronsdon M., Weatherholtz R., Raymond R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 196 (2007) 1211-1220
6. Ghaffar F., Barton T., Lozano J., Muniz L.S., Hicks P., Gan V., et al. Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis 39 (2004) 930-938
7. Hennessy T.W., Singleton R.J., Bulkow L.R., Bruden D.L., Hurlburt D.A., Parks D., et al. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a healthy disparity. Vaccine 23 (2005) 5464-5473
8. Huang S., Platt R., Rifas-Shiman S.L., Pelton S.I., Goldmann D., and Finkelstein J.A. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116 (2005) e408-e413
9. Obaro S.K., Adegbola R.A., Chang I., Banya W.A.S., Jaffar S., Mcadam K.W.J.P., et al. Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphteria, tetanus and pertussis vaccines in Gambian infants. Pediatr Infect Dis 19 (2000) 463-469
10. Yeh S.H., Zangwill K.M., Lee H., Chang S.-J., Wong V.I., Greenberg D.P., et al. Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants. Vaccine 21 (2003) 2627-2631
11. Frazao N., Brito-Avo A., Simas C., Saldanha J., Mato R., Nunes S., et al. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatr Infect Dis 24 3 (2005) 243-252
12. Millar E.V., O'Brien K.L., Watt J.P., Bronsdon M.A., Dallas J., Whitney C.G., et al. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Clin Infect Dis 43 (2006) 8-15
13. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomized double-blind efficacy study. Lancet 367 (2006) 740-748
14. Halloran M.E., Struchiner C.J., and Longini Jr. I.M. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol 146 10 (1997) 789-803
15. Bogaert D., de Groot R., and Hermans P.W.M. Streptoccocus pneumoniae colonisation: the key to pneumococcal disease. Lancet 4 (2004) 144-154
16. Smith T., Lehmann D., Montgomery J., Gratten M., Riley I.D., and Alpers M.P. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 111 1 (1993) 27-39
17. Auranen K., Arjas E., Leino T., and Takala A.K. Transmission of pneumococcal carriage in families: a latent Markov process model for binary longitudinal data. JASA 95 452 (2000) 1044-1053
18. Melegaro A., Gay N.J., and Medley G.F. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect 132 (2004) 433-441
19. Cauchemez S., Temime L., Valleron A.-J., Varon E., Thomas G., Guillemot D., et al. S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools. BMC Infect Dis 6 (2006) 14
20. Keiding N. Age-specific incidence and prevalence: a statistical perspective. JASA 154 (1991) 371-412
21. Becker N.G., and Starczak D.N. The effect of random vaccine response on the vaccination coverage required to prevent epidemics. Math Biosci 154 (1998) 117-135
22. Zeger S.L., and Liang K.-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130
23. Andersen P.K., and Keiding N. Multi-state models for event history analysis. Stat Methods Med Res 11 (2002) 91-115
24. R Development Core Team. R: a language and environment for statistical computing. Version 2. 7. 1 (2005), R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org/ ISBN 3-900051-07-0, URL: http://www.R-project.org [18.12.2008]
25. Gray B.M., Turner M.E., and Dillon Jr. H.C. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol 116 4 (1982) 692-703
26. Granat S.M., Zakaria M., Ollgren J., Herva E., Das M., Piirainen L., et al. Longitudinal study on pneumococcal carriage during the first year of life in Bangladesh. Pediatr Infect Dis 26 4 (2007) 319-324
27. Hill P.C., Cheung Y.B., Akisanya A., Sankareh K., Lahai G., Greenwood B.M., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis 46 (2008) 807-814
28. Nohynek H., Mäkelä H., Lucero M., Ugpo J., Auranen K., Forsyth S., et al. The impact of 11-valent pneumococcal conjugate vaccine (PCV) on nasopharyngeal (NP) carriage of Streptococcus pneumoniae (Pnc) in Philippine children. Abstracts of the 6th international symposium on pneumococci and pneumococcal diseases. Reykjavik, 8-12 June 2008 (2008) [abstract P3-134]
29. Barbour M.L., Mayon-White R.T., Coles C., Crook D.W., and Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 171 1 (1995) 93-98
30. Diggle P., Heagerty P., Liang K.-Y., and Zeger S. Analysis of longitudinal data. 2nd ed. (2002), Oxford University Press
31. Zocchetti C., Consonni D., and Bertazzi P.A. Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. Int J Epidemiol 26 1 (1997) 220-223
32. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis 19 3 (2000) 187-195
33. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 14 (2003) 1341-1348
34. O'Brien K.L., Moulton L.H., Reid R., Weatherholtz R., Oski J., Brown L., et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 362 9381 (2003) 355-361
35. Saaka M., Okoko B.J., Kohberger R.C., Jaffar S., Enwere G., Biney E.E., et al. Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia. Vaccine 26 (2008) 3719-3726
36. Broome C.V., Facklam R.R., and Fraser D.W. Pneumococcal disease after pneumococcal vaccination. An alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303 10 (1980) 549-552
37. Melegaro A., Choi Y., Pebody R., and Gay N. Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data. Am J Epidemiol 166 2 (2007) 228-235